This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Molson Coors (TAP) Stock Declines Despite Q2 Earnings Beat
by Zacks Equity Research
Molson Coors (TAP) beats earnings and sales estimates for second-quarter 2018 due to favorable global net pricing, realized cost savings, lower marketing spend and a lower tax rate.
Archer Daniels' (ADM) Stock Up on Q2 Earnings & Sales Beat
by Zacks Equity Research
Archer Daniels' (ADM) better-than-expected second-quarter results can be attributed to the company's strategic growth initiatives and robust cost-saving efforts.
P&G (PG) Beats on Q4 Earnings, Stock Falls on Revenue Miss
by Zacks Equity Research
Procter & Gamble (PG) reports better-than-expected earnings for fourth-quarter fiscal 2018 but misses sales estimates. Further, the company's fiscal 2019 guidance disappoints.
Market News For Jul 30, 2018
by Zacks Equity Research
Companies in the news are: CL, SBUX, SAM and EXPE
Colgate's (CL) Q2 Earnings In Line With Estimates, Sales Lag
by Zacks Equity Research
Colgate (CL) delivers first-quarter 2018 earnings in line with the Zacks Consensus Estimate but its sales lag. However, both the top and bottom line improves year over year.
Solid Organic Growth Aid Diageo's (DEO) Fiscal 2018 Earnings
by Zacks Equity Research
Diageo (DEO) delivers solid top- and bottom-line growth for the preliminary fiscal 2018, ended Jun 30, 2018, driven by strong organic sales and organic operating profit.
Boston Beer (SAM) Falls as Higher Costs Weigh on Q2 Earnings
by Zacks Equity Research
Boston Beer (SAM) delivers top- and bottom-line miss in second-quarter 2018, driven by higher costs and lower gross margins. It increases depletion and capex goals for 2018 and cuts gross margin view.
Will SBA Communications (SBAC) Beat Q2 Earnings on Leasing?
by Zacks Equity Research
SBA Communications' (SBAC) Q2 earnings are likely to be driven by year-over-year increase in top line.
Nu Skin (NUS) Q2 Earnings: Key Factors to Impact Results
by Zacks Equity Research
Nu Skin's (NUS) efforts to expand its customer base is expected to boost its Q2 results. However, margin pressure is likely to dent its bottom line.
AB InBev (BUD) Tops on Q2 Earnings & Sales, Simplifies Zones
by Zacks Equity Research
AB InBev (BUD) delivers top and bottom line beat in second-quarter 2018, backed by improving trends in key markets, ongoing revenue management initiatives and strong performance of premium brands.
Can Spectrum Brands' (SPB) Strategic Efforts Aid Q3 Earnings?
by Zacks Equity Research
Spectrum Brands (SPB) boasts a robust brand portfolio and undertakes various strategic measures to drive growth. These initiatives are likely to boost the company's third-quarter fiscal 2018 earnings.
Factors Setting the Tone for Procter & Gamble (PG) Q4 Earnings
by Zacks Equity Research
Despite a robust surprise trend, Procter & Gamble (PG) witnesses muted top-line growth due to multiple headwinds. However, the company's productivity and cost saving initiatives bode well.
Is a Surprise Coming for Boston Beer (SAM) This Earnings Season?
by Zacks Equity Research
Boston Beer (SAM) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Will Archer Daniels' (ADM) Strategic Efforts Aid Q2 Earnings?
by Zacks Equity Research
Archer Daniels (ADM) looks promising on the back of its portfolio management initiatives, cost-savings plan and Readiness program. These initiatives are likely to drive second-quarter 2018 results.
Will Robust Strategies Fuel Colgate's (CL) Q2 Earnings?
by Zacks Equity Research
Colgate (CL) is encouraged with its savings program along with brand building and productivity maximization initiatives. These, in turn, are likely to drive second-quarter 2018 results.
Zacks.com highlights: lululemon athletica, Perry Ellis International, Boston Beer Company, Medifast and Navigators Group
by Zacks Equity Research
Zacks.com highlights: lululemon athletica, Perry Ellis International, Boston Beer Company, Medifast and Navigators Group
Can FEMSA's (FMX) Efforts Aid Earnings Trend Reversal in Q2?
by Zacks Equity Research
FEMSA (FMX) witnesses mixed sentiments as investors are concerned about its dismal surprise history while its strategic initiatives reflect potential.
Buy These 5 Low-Beta Stocks to Tackle Volatility Woes
by Zacks Equity Research
We create a strategy that promises handsome returns from less-risky stocks if some parameters are taken into account.
Will Global Segment Drive Lamb Weston (LW) in Q4 Earnings?
by Zacks Equity Research
Aggressive pricing actions, solid performance in global segment and LTO innovations are likely to drive Lamb Weston's (LW) fourth quarter results.
Boston Beer, Keurig Dr Pepper and Microsoft highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Boston Beer, Keurig Dr Pepper and Microsoft highlighted as Zacks Bull and Bear of the Day
Bull of the Day: The Boston Beer Company (SAM)
by Brian Hamilton
EPS is expected to grow by +17.9% in its upcoming earnings report.
Factors Setting the Tone for AB InBev's (BUD) Q2 Earnings
by Zacks Equity Research
AB InBev's (BUD) dismal earnings trend and the volatility in certain key markets are concerns for its second-quarter results. However, a positive overall outlook and the brand strength infuse optimism.
Improving Depletions to Aid Boston Beer's (SAM) Q2 Earnings
by Zacks Equity Research
Boston Beer (SAM) is positioned to gain from its robust brands' portfolio, pricing and product innovations. Favorable depletion trends from new launches are likely to drive second-quarter results.
Factors Setting the Tone for Coca-Cola's (KO) Q2 Earnings
by Zacks Equity Research
Coca-Cola (KO) is witnessing a year-over-year decline in revenues for the last few quarters, primarily due to weak volumes and structural headwinds.
Can Savings Keep Kimberly-Clark (KMB) Afloat in Q2 Earnings?
by Zacks Equity Research
Kimberly-Clark (KMB) struggles with higher commodity costs and lower selling prices. However, robust cost reduction efforts are likely to aid performance in Q2.